Gavin Dabrera

15.4k total citations · 2 hit papers
61 papers, 3.2k citations indexed

About

Gavin Dabrera is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Gavin Dabrera has authored 61 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 17 papers in Epidemiology and 17 papers in Modeling and Simulation. Recurrent topics in Gavin Dabrera's work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 epidemiological studies (17 papers) and COVID-19 Clinical Research Studies (12 papers). Gavin Dabrera is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 epidemiological studies (17 papers) and COVID-19 Clinical Research Studies (12 papers). Gavin Dabrera collaborates with scholars based in United Kingdom, Sweden and Maldives. Gavin Dabrera's co-authors include Mary Ramsay, Jamie Lopez Bernal, Gayatri Amirthalingam, Simon Thelwall, Eileen Gallagher, Natalie Groves, Maria Zambon, Nick Andrews, Julia Stowe and Elise Tessier and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Gavin Dabrera

59 papers receiving 3.1k citations

Hit Papers

Effectiveness of Covid-19 Vaccines against the B.1.617.2 ... 2021 2026 2022 2024 2021 2021 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin Dabrera United Kingdom 17 2.2k 857 741 576 279 61 3.2k
Elise Tessier United Kingdom 15 2.4k 1.1× 1.2k 1.4× 829 1.1× 503 0.9× 130 0.5× 32 3.3k
Sara E. Oliver United States 20 1.6k 0.7× 1.0k 1.2× 384 0.5× 677 1.2× 250 0.9× 54 2.9k
Bradley K. Ackerson United States 26 2.1k 1.0× 929 1.1× 396 0.5× 1.1k 1.9× 121 0.4× 100 3.4k
Julia Stowe United Kingdom 31 3.4k 1.5× 1.6k 1.9× 912 1.2× 1.3k 2.2× 278 1.0× 82 5.2k
Ruth Simmons United Kingdom 18 2.5k 1.1× 944 1.1× 749 1.0× 480 0.8× 59 0.2× 69 3.4k
Meera Chand United Kingdom 20 2.4k 1.1× 677 0.8× 656 0.9× 449 0.8× 63 0.2× 50 3.3k
Colin Campbell United Kingdom 13 1.7k 0.8× 602 0.7× 503 0.7× 395 0.7× 61 0.2× 44 2.3k
Joseph A. Lewnard United States 26 1.4k 0.6× 352 0.4× 695 0.9× 833 1.4× 164 0.6× 74 2.6k
Jim McMenamin United Kingdom 34 1.6k 0.7× 755 0.9× 639 0.9× 2.3k 4.0× 204 0.7× 109 4.0k
Natalie Groves United Kingdom 13 1.8k 0.8× 653 0.8× 574 0.8× 219 0.4× 58 0.2× 23 2.3k

Countries citing papers authored by Gavin Dabrera

Since Specialization
Citations

This map shows the geographic impact of Gavin Dabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Dabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Dabrera more than expected).

Fields of papers citing papers by Gavin Dabrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Dabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Dabrera. The network helps show where Gavin Dabrera may publish in the future.

Co-authorship network of co-authors of Gavin Dabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Dabrera. A scholar is included among the top collaborators of Gavin Dabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Dabrera. Gavin Dabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirsebom, Freja, Nick Andrews, Julia Stowe, et al.. (2024). Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in England. EClinicalMedicine. 71. 102587–102587. 6 indexed citations
2.
Dabrera, Gavin. (2024). H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans. Current Opinion in Infectious Diseases. 37(5). 431–435. 2 indexed citations
3.
Flannagan, Joe, Dimple Chudasama, Russell Hope, et al.. (2023). Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks. Epidemiology and Infection. 151. e191–e191. 1 indexed citations
4.
Flannagan, Joe, Elise Tessier, Dimple Chudasama, et al.. (2023). Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19. Epidemiology and Infection. 151. e51–e51.
5.
Twohig, Katherine A., Katie Harman, Asad Zaidi, et al.. (2023). Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection. Epidemiology and Infection. 151. e169–e169. 1 indexed citations
7.
Harman, Katie, Sophie Nash, Harriet Webster, et al.. (2023). Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England. Influenza and Other Respiratory Viruses. 17(5). e13150–e13150. 14 indexed citations
8.
Twohig, Katherine A., Asad Zaidi, Inês Campos-Matos, et al.. (2023). Rapid rise in COVID-19 among young people in England – learning for the future. Public Health. 218. 136–138. 1 indexed citations
9.
Nyberg, Tommy, Katie Harman, Asad Zaidi, et al.. (2022). Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages. The Journal of Infectious Diseases. 226(5). 808–811. 6 indexed citations
11.
Webster, Harriet, Tommy Nyberg, Mary Sinnathamby, et al.. (2022). Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England. Nature Communications. 13(1). 6053–6053. 18 indexed citations
12.
Blomquist, Paula, Ulf Schaefer, Steven G. Platt, et al.. (2021). Risk of symptomatic COVID‐19 due to aircraft transmission: a retrospective cohort study of contact‐traced flights during England’s containment phase. Influenza and Other Respiratory Viruses. 15(3). 336–344. 12 indexed citations
13.
Zhao, Hongxin, Frances Parry‐Ford, Gavin Dabrera, et al.. (2020). Six-year experience of detection and investigation of possible Middle East Respiratory Syndrome coronavirus cases, England, 2012–2018. Public Health. 189. 141–143. 1 indexed citations
14.
Coles, Simon J., Patrick Lillie, C.J. Duncan, et al.. (2020). COVID-19: public health management of the first two confirmed cases identified in the UK. Epidemiology and Infection. 148. e194–e194. 4 indexed citations
15.
Dabrera, Gavin, et al.. (2020). Legionellosis incidents associated with spa pools, England, 2002–2018. Public Health. 185. 232–234. 3 indexed citations
16.
Freeman, Rachel, Gavin Dabrera, Chris Lane, et al.. (2015). Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak ofSalmonellaMikawasima in the UK, 2013. Epidemiology and Infection. 144(5). 968–975. 21 indexed citations
17.
Dabrera, Gavin, Gayatri Amirthalingam, Nick Andrews, et al.. (2014). A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013. Clinical Infectious Diseases. 60(3). 333–337. 282 indexed citations
19.
Dabrera, Gavin, et al.. (2013). Cold weather threats to health: how does Europe prepare?. Public Health. 127(10). 952–954. 2 indexed citations
20.
Dabrera, Gavin, et al.. (2012). Is preparedness for CBRN incidents important to general practitioners in East London?. PubMed. 6(1). 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026